Panoptes is a privately held clinical stage biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.
Since its foundation in year 2013, Panoptes has successfully developed two drug products, PaniJect and PaniDrop, which are currently investigated in clinical studies to treat severe eye ...
Panoptes is a privately held clinical stage biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.
Since its foundation in year 2013, Panoptes has successfully developed two drug products, PaniJect and PaniDrop, which are currently investigated in clinical studies to treat severe eye diseases with high unmet medical need.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.